New Key Statistics Module, Z-Score and F-Score
SHSE:601089 Key Ratios
Market Cap ¥ M | 7,252.80 |
Enterprise Value ¥ M | 4,943.74 |
P/E(ttm) | 14.25 |
PE Ratio without NRI | 14.13 |
Forward PE Ratio | -- |
Price/Book | 2.10 |
Price/Sales | 2.18 |
Price/Free Cash Flow | 34.75 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.37 |
Revenue (TTM) ¥ M | 3,323.00 |
EPS (TTM) ¥ | 1.06 |
Beneish M-Score | -2.42 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 12.30 |
y-y EBITDA Growth Rate % | 1.70 |
EV-to-EBIT | 8.64 |
EV-to-EBITDA | 8.64 |
PEG | 1.15 |
Shares Outstanding M | 480.00 |
Net Margin (%) | 15.28 |
Operating Margin % | 15.60 |
Pre-tax Margin (%) | 17.10 |
Quick Ratio | 2.99 |
Current Ratio | 3.33 |
ROA % (ttm) | 11.42 |
ROE % (ttm) | 15.11 |
ROIC % (ttm) | 35.93 |
Dividend Yield % | 2.65 |
Altman Z-Score | 6.48 |
SHSE:601089 Number of Guru Trades
SHSE:601089 Volume of Guru Trades
Gurus Latest Trades with SHSE:601089
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:601089 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Beijing Winsunny Pharmaceutical Co Ltd Insider Transactions
No Available Data